Batelapine
Jump to navigation
Jump to search
This article relies largely or entirely on a single source. (April 2021) |
Clinical data | |
---|---|
Other names | CGS-13429 |
Routes of administration | By mouth |
ATC code |
|
Pharmacokinetic data | |
Elimination half-life | 8.1 Hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H20N6 |
Molar mass | 296.378 g·mol−1 |
3D model (JSmol) | |
| |
|
Batelapine (developmental code name CGS-13429) is a structural analogue of clozapine which was investigated as a potential antipsychotic.[1][2]
References
- ^ Chovan JP, Vermeulen JD (September 1989). "High-performance liquid chromatographic method for a clozapine analogue, CGS 13429, and its N-oxide and desmethyl metabolites". Journal of Chromatography. 494: 413–9. doi:10.1016/s0378-4347(00)82697-3. PMID 2573611.
- ^ "Batelapine - AdisInsight".
External links
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles needing additional references from April 2021
- All articles needing additional references
- Drugs not assigned an ATC code
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Abandoned drugs
- Antipsychotics
- Piperazines
- Triazolobenzodiazepines
- Tricyclic compounds
- All stub articles
- Psychoactive drug stubs